Correlation Between GeneDx Holdings and Humacyte

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GeneDx Holdings and Humacyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GeneDx Holdings and Humacyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GeneDx Holdings Corp and Humacyte, you can compare the effects of market volatilities on GeneDx Holdings and Humacyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GeneDx Holdings with a short position of Humacyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of GeneDx Holdings and Humacyte.

Diversification Opportunities for GeneDx Holdings and Humacyte

0.17
  Correlation Coefficient

Average diversification

The 3 months correlation between GeneDx and Humacyte is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding GeneDx Holdings Corp and Humacyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Humacyte and GeneDx Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GeneDx Holdings Corp are associated (or correlated) with Humacyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Humacyte has no effect on the direction of GeneDx Holdings i.e., GeneDx Holdings and Humacyte go up and down completely randomly.

Pair Corralation between GeneDx Holdings and Humacyte

Considering the 90-day investment horizon GeneDx Holdings Corp is expected to generate 0.81 times more return on investment than Humacyte. However, GeneDx Holdings Corp is 1.23 times less risky than Humacyte. It trades about 0.18 of its potential returns per unit of risk. Humacyte is currently generating about 0.1 per unit of risk. If you would invest  333.00  in GeneDx Holdings Corp on November 9, 2024 and sell it today you would earn a total of  5,884  from holding GeneDx Holdings Corp or generate 1766.97% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy99.25%
ValuesDaily Returns

GeneDx Holdings Corp  vs.  Humacyte

 Performance 
       Timeline  
GeneDx Holdings Corp 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days GeneDx Holdings Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Humacyte 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Humacyte are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Humacyte showed solid returns over the last few months and may actually be approaching a breakup point.

GeneDx Holdings and Humacyte Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GeneDx Holdings and Humacyte

The main advantage of trading using opposite GeneDx Holdings and Humacyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GeneDx Holdings position performs unexpectedly, Humacyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Humacyte will offset losses from the drop in Humacyte's long position.
The idea behind GeneDx Holdings Corp and Humacyte pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA